New drug shows promise against treatment-resistant non-small cell lung cancer

Share this content:
New drug shows promise against treatment-resistant non-small cell lung cancer
New drug shows promise against treatment-resistant non-small cell lung cancer
A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial. Approximately 10-15% of ...
READ FULL ARTICLE From News Medical
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »